Diagnosing Invasive Candidiasis
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Cultures are negative in ∼50% of invasive candidiasis. Data are emerging for the performance of nonculture tests such as mannan/antimannan, Candida albicans germ tube antibody, 1,3-β- d -glucan, PCR, and the T2Candida panel in diagnosing both candidemia and deep-seated candidiasis. In most settings, positive predictive values of nonculture test are low, and negative predictive values are high. For tests to be useful, clinicians must understand the pretest likelihood of invasive candidiasis and test performance for the most common disease manifestation in a given patient. This paper reviews nonculture Candida diagnostics and discusses how they might be used effectively in patient care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“One limitation is that we may be missing sterile site infections as well as candidemic patients with deep-seated infections due to limitations with current detection methods [28].”
From Invasive candidiasis species distribution and trends, United States, 2009-2017 (2021) · cites this paper as [28]
The cited source says what the claim attributes to it.
In the citing paper
“with the sensitivity of blood culture around or less than 50% [28].”
From Invasive candidiasis species distribution and trends, United States, 2009-2017 (2021) · cites this paper as [28]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Other studies, however, did not observe an association between antimicrobial timing and mortality (112-117).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [115]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Andes, D. R., Safdar, N., Baddley, J. W., Playford, G., Reboli, A. C., Rex, J. H., Sobel, J. D., Pappas, P. G., Kullberg, B. J., & for the Mycoses Study Group (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis021 · Cited by 793 · cited 1×
“Timely antifungal therapy and source control are crucial determinants of survival in patients with invasive candidiasis (1, 2).”
BackgroundClancy, C. J., & Nguyen, M. H. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit006 · Cited by 688 · cited 5×
“Cultures of material collected from deep sites of infection are also only 50% sensitive, likely reflecting small sample volumes and uneven distribution and low burdens of Candida cells (3).”
BackgroundInfluentialSelf-citation-D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis
Karageorgopoulos, D. E., Vouloumanou, E. K., Ntziora, F., Michalopoulos, A., Rafailidis, P. I., & Falagas, M. E. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq206 · Cited by 538 · cited 1×
“65% to 85% and 75% to 85%, respectively) (12, 13).”
T2 Magnetic Resonance Assay for the Rapid Diagnosis of Candidemia in Whole Blood: A Clinical Trial
Mylonakis, E., Clancy, C. J., Ostrosky-Zeichner, L., Garey, K. W., Alangaden, G. J., Vazquez, J. A., Groeger, J. S., Judson, M. A., Vinagre, Y.-M., Heard, S. O., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu959 · Cited by 443 · cited 10×
“FDA clearance of T2Candida was based on data from the multicenter DIRECT trial, which included 1,500 control patients with Candida-negative blood cultures, 6 patients with Candida-positive blood cultures, and 250 contrived blood specimens spiked with C. albicans, C. glabrata, C. parapsilosis, C. tropicalis, or C. krus…”
InfluentialSelf-citationPCR Diagnosis of Invasive Candidiasis: Systematic Review and Meta-Analysis
Avni, T., Leibovici, L., & Paul, M. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01602-10 · Cited by 389 · cited 1×
“and 92% (95% CI, 87 to 98%), respectively (17).”
Onishi, A., Sugiyama, D., Kogata, Y., Saegusa, J., Sugimoto, T., Kawano, S., Morinobu, A., Nishimura, K., & Kumagai, S. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.05267-11 · Cited by 328 · cited 1×
“65% to 85% and 75% to 85%, respectively) (12, 13).”
Mikulska, M., Calandra, T., Sanguinetti, M., Poulain, D., Viscoli, C., & the Third European Conference on Infections in Leukemia Group (2010) · Critical Care · doi:10.1186/cc9365 · Cited by 319 · cited 1×
“In a meta-analysis of 14 studies, the sensitivities and specificities of mannan and antimannan for invasive candidiasis were 58% and 93%, and 59% and 86%, respectively (7).”
BackgroundNguyen, M. H., Wissel, M. C., Shields, R. K., Salomoni, M. A., Hao, B., Press, E. G., Shields, R. M., Cheng, S., Mitsani, D., Vadnerkar, A., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis200 · Cited by 290 · cited 2×
“The sensitivity and specificity of PCR are estimated from the studies of deep-seated candidiasis cited in the text and in Table 1 (9, 10, 22).”
BackgroundSelf-citationPfaller, M. A., Messer, S. A., Moet, G. J., Jones, R. N., & Castanheira, M. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.02.016 · Cited by 274 · cited 6×
“FDA clearance of T2Candida was based on data from the multicenter DIRECT trial, which included 1,500 control patients with Candida-negative blood cultures, 6 patients with Candida-positive blood cultures, and 250 contrived blood specimens spiked with C. albicans, C. glabrata, C. parapsilosis, C. tropicalis, or C. krus…”
BackgroundInfluentialLaboratory diagnosis of invasive candidiasis.
Ellepola, A. N. B., & Morrison, C. J. (2005) · PubMed · Cited by 265
Cited by
Items 101–200 of 323
Laboratory Diagnosis of Candidiasis
Musinguzi, B., Sande, O. J., Mboowa, G., Baguma, A., Itabangi, H., & Achan, B. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.106359 · Cited by 15
O’Donnell, M., Shields, R. K., Marini, R. V., Groetzinger, L. M., Potoski, B. A., Falcione, B. A., Shah, S., McCreary, E. K., Clarke, L. G., Brant, E. B., et al. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad538 · Cited by 15
“Such algorithms should define the patient populations most likely to benefit from the test, as the performance of T2Candida, like other nonculture diagnostics, is dependent upon the prevalence of disease [11].”
BackgroundMethodInfluentialSelf-citationPerformance of Multiplex PCR and β-1,3-D-Glucan Testing for the Diagnosis of Candidemia
Koc, Ö., Kessler, H. H., Hoenigl, M., Wagener, J., Suerbaum, S., Schubert, S., & Dichtl, K. (2022) · Journal of Fungi · doi:10.3390/jof8090972 · Cited by 14
“BC diagnostics of candidemia are impeded by several drawbacks including low sensitivity and long turnaround time [7,11,15].”
BackgroundInfluentialWhen to Initiate Antifungal Treatment in COVID-19 Patients with Secondary Fungal Co-infection
Pruthi, H. S. (2022) · Current Clinical Microbiology Reports · doi:10.1007/s40588-022-00184-0 · Cited by 13
Invasive Fungal Infections in Immunocompromised Conditions: Emphasis on COVID-19
Kaur, M., Thakur, P., Verma, N., Choksket, S., Harshvardhan, Korpole, S., Devadatha, B., & Grover, V. (2024) · Current Microbiology · doi:10.1007/s00284-024-03916-1 · Cited by 13
“Major risk factors in ICU admitted patients include the excessive use of antibiotics, poor hand hygiene, central venous catheters, and corticosteroids; invasive Candida infections play a significant co-morbidity burden [59].”
Management of Intra-Abdominal Candidiasis in Intensive Care Setting: A Narrative Review
Pais, M. M., Zaragoza, R., Martín‐Loeches, I., Gómez-Bertomeu, F., & Rodríguez, A. H. (2025) · Journal of Fungi · doi:10.3390/jof11050362 · Cited by 12
“Se: 80–95% Sp: 90–98% PPV: up to 90% NPV: 95% [33] Early and direct detection of Candida DNA from blood or sterile fluids, often before cultures become positive.”
Diagnostic Challenges in Fungal Coinfections Associated With Global COVID‐19
Shahin-jafari, A., Nejad, A. S. M., Faraji, H., Abdel-Moneim, A. S., Asgari, S., Karami, H., Kamali, A., Vakilabad, A. A. K., Habibi, A., & Faramarzpour, M. (2025) · Scientifica · doi:10.1155/sci5/6840605 · Cited by 12
“MALDI-TOF MS technology can rapidly identify yeast species directly from blood cultures within minutes, eliminating the need for sub-culturing [154].”
InfluentialHuang, D., Li, H., Lin, Y., Lin, J., Li, C., Kuang, Y., Zhou, W. J., Huang, B. S., & Wang, P. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.981823 · Cited by 12
“Fungal infections were diagnosed by combining clinical characteristics and blood levels of 1,3-b-D-glucan according to standard guidelines (Calley and Warris, 2017; King et al., 2017; Clancy and Nguyen, 2018; Warris et al., 2019; Weimer et al., 2021).”
MethodT2Candida assay: diagnostic performance and impact on antifungal prescribing
de Jesus, R. P., Houston, H., Schutte, A. H. J., Morris-Jones, S. D., Stone, N. R. H., Gorton, R., & Pollara, G. (2023) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlad035 · Cited by 12
Zhang, X. R., Ma, T., Wang, Y. C., Hu, S., & Yang, Y. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.04912-22 · Cited by 12
Existing and emerging therapies for the treatment of invasive candidiasis and candidemia
Bels, D. D., Maillart, E., Bambeke, F. V., Redant, S., & Honoré, P. M. (2022) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2022.2142207 · Cited by 12
“On this basis, diagnostic tests must identify three situations, namely candidemia without deep-seated candidiasis, deep-seated candidiasis in the absence of candidemia and, lastly, candidemia associated with deep-seated candidiasis [17].”
BackgroundRecent advances in the clinical development of antifungal vaccines: a narrative review
Alapan, D., Bisweswar, O., Prasenjit, S., Prasanjit, D., & Bandyopadhyay, A. (2024) · Frontiers in Tropical Diseases · doi:10.3389/fitd.2024.1446477 · Cited by 11
“Deep-seated infection due to Candida occurs after disrupting host mucosal protection or indwelling medical devices and invasion into the bloodstream (39).”
Fungal-Induced Hemophagocytic Lymphohistiocytosis: A Literature Review in Non-HIV Populations
Chiu, C., Hicklen, R., & Kontoyiannis, D. P. (2025) · Journal of Fungi · doi:10.3390/jof11020158 · Cited by 11
“A similar challenge exists for other IFIs; for example, cultures are negative in ~50% of invasive candidiasis cases, and <20% of deep‑seated candidiasis cases lead to candidemia [154].”
Chastain, D. B., White, B. P., Tu, P. J., Chan, S., Jackson, B., Kubbs, K. A., Bandali, A., McDougal, S., Henao‐Martínez, A. F., & Cluck, D. B. (2023) · Annals of Pharmacotherapy · doi:10.1177/10600280231175201 · Cited by 11
“…Blood Culture Identification 2 (BCID2) (BioFire, Salt Lake City, Utah), 20 peptide nucleic acid fluorescence in situ hybridization (PNA-FISH), 8,21 T2Candida Panel (T2 Biosystems, Lexington, Massachusetts), 17,22 or ePlex BCID Panels (GenMark Diagnostics, Carlsbad, California) 23,24 (Table 1).”
BackgroundUnresolved issues in the diagnosis of catheter related candidemia: A position paper
Soriano-Martín, A., Muñóz, P., García‐Rodríguez, J., Cantón, R., Vena, A., Bassetti, M., & Bouza, E. (2023) · Revista Española de Quimioterapia · doi:10.37201/req/112.2023 · Cited by 11
“Its main limitations are positivity in non-Candida spp . fungal infections and the existence of false positives in several situations [102,103].”
BackgroundFalces‐Romero, I., Romero‐Gómez, M. P., Moreno-Ramos, F., Mingorance, J., García‐Rodríguez, J., & Cendejas‐Bueno, E. (2020) · Medical Mycology · doi:10.1093/mmy/myaa056 · Cited by 11
Management of invasive candidiasis in the ICU: Challenges and advances (Review)
Elmasry, W. G., ABDELBAKY, A., & Awad, A. H. (2025) · Medicine International · doi:10.3892/mi.2025.278 · Cited by 10
Scaglione, G., Colaneri, M., Offer, M., Galli, L., Borgonovo, F., Genovese, C., Fattore, R., Schiavini, M., Taino, A., Calloni, M. V., et al. (2024) · Microorganisms · doi:10.3390/microorganisms12081597 · Cited by 10
“…deep-seated candidiasis consisted of a specialist-driven diagnosis of Candida spp. invasion of the eye, lungs, heart, gastrointestinal tract, central nervous system, or other parenchymal organs, and at least one positive blood culture for Candida spp., according to international guidelines [14].”
BackgroundCandida spp. DNA Extraction in the Age of Molecular Diagnosis
Codreanu, S. I., & Ciurea, C. N. (2023) · Microorganisms · doi:10.3390/microorganisms11040818 · Cited by 10
Rapid detection of biofilm‐producing Candida species via MALDI‐TOF mass spectrometry
de Aguiar, P. A. D. F., Menezes, R. D. P., Penatti, M. P. A., Moreira, T. A., Pimenta, J. P., Silva, N. B. S., & Röder, D. V. D. B. (2021) · Journal of Applied Microbiology · doi:10.1111/jam.15066 · Cited by 10
“Candidemia is associated with high mortality rates due to late diagnosis and treatment (Clancy and Nguyen 2018; Pappas et al. 2018; Vit alis et al. 2020).”
BackgroundHelweg‐Larsen, J., Steensen, M., Pedersen, F. M., Jensen, P. B., Perch, M., Møller, K., Olesen, B. R., Søderlund, M., & Arendrup, M. C. (2021) · Journal of Fungi · doi:10.3390/jof7121044 · Cited by 9
“Further, the mannan antibody test was not assessed, due to the poor performance of this biomarker [19,37,41].”
BackgroundXia, J., Huang, W. E., Lu, F., Li, M., & Wang, B. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s368792 · Cited by 9
“However, their overall diagnostic sensitivity and specificity are usually unsatisfying.(8) It turns out that host factors and clinical features in subjects with invasive Candida infections become increasingly complicated in current clinical settings, and relevant hematological/pathological tests are often time-consumi…”
BackgroundLi, W., Chen, G., Lin, F., Yang, H., Cui, Y., Lu, R., Song, C., Li, H., Li, Y., & Pan, P. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1097574 · Cited by 9
“For example, BDG is a cell wall component of Candida, which can be continuously released into blood in the process of IC (Clancy and Nguyen, 2018; Yoshida, 2021).”
BackgroundMethodCandida die-off: Adverse effect and neutralization with phytotherapy approaches
Jaiswal, N., & Kumar, A. (2023) · Toxicon · doi:10.1016/j.toxicon.2023.107555 · Cited by 9
Guo, M., & Tong, Z. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s329323 · Cited by 9
Invasive fungal infections in non-neutropenic patients
Kreitmann, L., Blot, S. I., & Nseir, S. (2024) · Intensive Care Medicine · doi:10.1007/s00134-024-07683-2 · Cited by 9
“It has a low specificity, but its sensitivity (74–86% [6]) may be high enough to rule out IC in settings where the prevalence is low (negative predictive value > 95% [7]).”
Infections in acute liver failure – Assessment, prevention, and management
Venkatakrishnan, G., Amma, B. S. P. T., Menon, R. N., Rajakrishnan, H., & Surendran, S. (2024) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2024.101958 · Cited by 8
Li, Y., Qian, Z., Chen, H., Zhang, S., Wang, R., Yu, S., Chen, L., Wang, L., Xu, S., & Tao, Y. K. (2024) · Retina · doi:10.1097/iae.0000000000004073 · Cited by 8
“19 It is noteworthy that the consistency rate of pathogen identi fi cation by culture was 100%.”
BackgroundSpectrum and management of rare Candida /yeast infections in Kuwait in the Middle East
Ahmad, S., Asadzadeh, M., Al‐Sweih, N., & Khan, Z. (2024) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361241263733 · Cited by 8
Highly specific and rapid molecular detection of Candida glabrata in clinical samples
Hernández-Carreón, O., Hernández-Howell, C., Hernández-Hernández, G., Herrera-Basurto, M. S., González-Gómez, B. E., Gutiérrez‐Escobedo, G., García-Calderón, N. I., Barrón-Pastor, D., Peñas, A. D. L., & Castaño, I. (2021) · Brazilian Journal of Microbiology · doi:10.1007/s42770-021-00584-2 · Cited by 8
“To diagnose candidemia, blood cultures are still the gold standard used in the clinic, but the sensitivity is only ~ 50% and the species are not identified [12, 13].”
BackgroundForster, J., Dichtl, K., & Wagener, J. (2022) · Mycoses · doi:10.1111/myc.13421 · Cited by 8
Zubkowicz, M., Held, J., Baier, M., Pletz, M. W., Kesselmeier, M., Hagel, S., & Bahrs, C. (2020) · Mycoses · doi:10.1111/myc.13207 · Cited by 8
Longitudinal Evaluation of Plasma Cytokine Levels in Patients with Invasive Candidiasis
Wunsch, S., Zurl, C., Strohmaier, H. M., Meinitzer, A., Rabensteiner, J., Posch, W., Lass‐Flörl, C., Cornely, O. A., Pregartner, G., König, E., et al. (2021) · Journal of Fungi · doi:10.3390/jof7020101 · Cited by 8
“The strength of non-culture-based methods like 1,3-beta-D Glucan testing (BDG) is its high negative predictive values, whereas positive predictive values are low [19].”
BackgroundMenu, E., Landier, J., Prudent, E., Ranque, S., & L’Ollivier, C. (2021) · Journal of Fungi · doi:10.3390/jof7030228 · Cited by 8
Dudakova, A., Blei, C., Groß, U., & Schulze, M. H. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.03.054 · Cited by 8
Biomarker-guided antifungal stewardship policies for patients with invasive candidiasis
Honarvar, B., Lankarani, K. B., Taghavi, M., Vahedi, G., & Mortaz, E. (2019) · Current Medical Mycology · doi:10.18502/cmm.4.4.385 · Cited by 8
“recommended as a reliable combinatory diagnostic method for Candida species, along with culture-based evaluation tests [11, 31, 34].”
BackgroundMethodInfluentialPadela, S. P. S. H. A. I. (2021) · Avicenna Journal of Medicine · doi:10.1055/s-00051312 · Cited by 8
A Simple, Fast, and Reliable Method for the Identification of Candida albicans
Chiang, S. J., Chien, M.-K., Tsai, C.-Y., Hsiao, J. C., Koo, F.-H., Yen, Y., Chou, Y.-C., & Cheng, C. (2024) · Environmental Health Insights · doi:10.1177/11786302241272398 · Cited by 7
Xiang, Y., Wu, J., Li, F., Sun, S., Liu, X., & Guo, J. (2025) · Alexandria Engineering Journal · doi:10.1016/j.aej.2025.01.085 · Cited by 7
Diagnostic Biomarkers for Invasive Candidiasis: A Clinician-Oriented Review
Smâdu, S., Tetradov, S. C., Ene, L., Oprişan, C., Lazăr, D. Ș., & Florescu, S. A. (2026) · Journal of Fungi · doi:10.3390/jof12010055 · Cited by 7
“C . parapsilosis and C. auris produce lower detectable levels of circulating antigen, which translate into lower sensitivity and can lead to potential diagnostic delays, particularly in cases when diagnosis is critical [14,32,33].”
Liu, C., Yao, X., Liu, C., You, S., Qi, W. D., & Wang, M. (2023) · Analytical Methods · doi:10.1039/d3ay00259d · Cited by 7
Kim, J. H., Suh, J. W., Kim, J. Y., Kim, S. B., Yoon, Y. K., Sohn, J. W., & Kim, M. J. (2020) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2020.101102 · Cited by 7
Candida Infections in Solid Organ Transplantation
Barros, N., & Mansour, M. K. (2021) · Springer eBooks · doi:10.1007/978-3-030-25869-6_43 · Cited by 7
Shukla, M., Chandley, P., Kaur, H., Ghosh, A. K., Rudramurthy, S. M., & Rohatgi, S. (2021) · Journal of Fungi · doi:10.3390/jof7120999 · Cited by 7
“Various studies have demonstrated the use the (1,3)-β-Dglucan-based assay in the diagnosis of Candida infection [31,32].”
BackgroundTherapeutic Drug Monitoring and Biomarkers; towards Better Dosing of Antimicrobial Therapy
Wehbe, E., Patanwala, A. E., Lu, C. Y., Kim, H. Y., STOCKER, S. L., & Alffenaar, J. C. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16050677 · Cited by 8
“BDG is released into the bloodstream during tissue invasion [28].”
BackgroundEvaluation of Serum Biomarkers for Improved Diagnosis of Candidemia
Kinet-Poleur, A., Deckers, C., Albichr, I. S., Bogaerts, P., Honoré, P. M., Bulpa, P. A., Ausselet, N., Forêt, F., Kidd, F., Huang, T., et al. (2025) · Journal of Fungi · doi:10.3390/jof11030224 · Cited by 7
“This makes BDG a valuable tool for ruling out fungal infections in patients with suspected IFIs [17–19].”
Disseminated Invasive Candidiasis in an Immunocompetent Host.
Navarathna, D. H. M. L. P., Rachut, E., Jinadatha, C., & Prakash, G. (2019) · PubMed · Cited by 7
Yashunsky, D. V., Dorokhova, V. S., Сергеевна, К. Б., Paulovičová, E., Krylov, V. B., & Nifantiev, N. E. (2021) · Russian Chemical Bulletin · doi:10.1007/s11172-021-3334-9 · Cited by 7
Opportunistic Fungal Invasion in COVID-19 Pandemic: A Critical Review in Diagnosis and Management
Sharma, A., Bano, G., Malik, A., Rasool, Y., Manzar, S., Singh, T., & Maity, M. K. (2023) · Avicenna Journal of Medicine · doi:10.1055/s-0043-1770921 · Cited by 7
“24,25 23, 26 – 28”
Recognition and Management of Angioinvasive Fungal Infections
Mihailides, L. I., Croda, M., & Forrestel, A. K. (2020) · Current Dermatology Reports · doi:10.1007/s13671-020-00296-0 · Cited by 6
Non-superficial Cutaneous Manifestations by Candida Species
Figueroa-Ramos, G., Bermúdez‐Rodríguez, S. P., Gatica‐Torres, M., Barrera‐Godínez, A., Bonifáz, A., & Domínguez‐Cherit, J. (2024) · Current Fungal Infection Reports · doi:10.1007/s12281-024-00485-5 · Cited by 6
“Different diagnostic tests are required to identify each of the three IC subtypes [41].”
Bal, A. M. (2020) · Mycoses · doi:10.1111/myc.13196 · Cited by 6
CANDIDA DIAGNOSTIC PLATFORMS: ESSENTIAL IN EARLY MANAGEMENT OF CANDIDA INFECTIONS
Hassan, Y., Aminu, I., & Abbdullahi, S. A. (2021) · FUDMA Journal of Sciences · doi:10.33003/fjs-2021-0502-522 · Cited by 6
“According to Clancy and Nguyen (2018), the culture is only positive in ~40% of patients with candidemia, and infection is complicated by deep-seated infection.”
BackgroundRISCO EMERGENTE DAS INFECÇÕES FÚNGICAS INVASIVAS: REVISÃO DA LITERATURA
Araújo, R. K. S., Frota, V. C. D. A., Santana, M. D. S., & Souza, N. R. (2023) · Revista Ibero-Americana de Humanidades, Ciências e Educação · doi:10.51891/rease.v9i8.10892 · Cited by 6
Lam, S. W., & Bass, S. N. (2019) · Journal of Pharmacy Practice · doi:10.1177/0897190019831162 · Cited by 6
The burden of serious fungal infections in Azerbaijan
Huseynov, R. M., Javadov, S., Osmanov, A., Khasiyev, S., Valiyeva, S. R., Almammadova, E., & Denning, D. W. (2021) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361211043969 · Cited by 6
Gening, M. L., Polyanskaya, A. V., Kuznetsov, A. N., Titova, A. D., Yudin, V. I., Yashunsky, D. V., Tsvetkov, Y. E., Yudina, O. N., Krylov, V. B., & Nifantiev, N. E. (2024) · Biochemistry (Moscow) · doi:10.1134/s0006297924120083 · Cited by 5
“Use of combination of tests for mannan and complementary antibodies increases sensitivity and specificity of the IC diagnosis [11].”
Novy, E., Esposito, M., Debourgogne, A., & Roger, C. (2025) · Journal of Fungi · doi:10.3390/jof11020091 · Cited by 5
“Detecting Candida (or any microorganism) in peritoneal fluid is challenging due to several factors [18]:”
Tavares, E. R., Santos, V. P., de Castro, I. M., Borges, P. H. G., Silva-Rodrigues, G., Olak, A. P. S., Bartolomeu-Gonçalves, G., Santos, J. P., Morey, A. T., Ishida, K., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199411 · Cited by 5
Diagnostic Potential of a Recombinant Candida albicans Hyr1 Protein
Bregón-Villahoz, M., Díez, A., Galech, J., Cuétara, M. S., Carrano, G., Moragues, M. D., Fernandez-de-Larrinoa, Í., & Arrieta-Aguirre, I. (2025) · Mycopathologia · doi:10.1007/s11046-025-01025-6 · Cited by 5
“Several studies have proved the efficacy of the CAGTA titre determination as diagnostic and prognostic tool even though its sensitivity and specificity are moderate [11, 12]; however, it should be noted that it is a subjective and non-automatable method.”
Diagnostic Approaches to Invasive Candidiasis: Challenges and New Perspectives
Slepčanová, H., Dobiáš, R., Langer, A. B. S., Káňová, M., & Hamal, P. (2025) · Mycopathologia · doi:10.1007/s11046-025-01035-4 · Cited by 5
“Although iron chelators have not been mentioned as diagnostic tools in this context, the importance of iron metabolism in Candida pathogenicity suggests that further research in this area could be beneficial [31–33].”
Does leukotriene F4 play a major role in the infection mechanism of Candida sp.?
Melo, C. F. O. R., Bachur, L. F., Delafiori, J., Dabaja, M. Z., de Oliveira, D. N., Guerreiro, T. M., Tararam, C. A., Busso-Lopes, A. F., Moretti, M. L., & Catharino, R. R. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104394 · Cited by 5
Bregón-Villahoz, M., Menéndez-Manjón, P., Carrano, G., Díez, A., Arrieta-Aguirre, I., Fernandez-de-Larrinoa, Í., & Moragues, M. D. (2024) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2024.116311 · Cited by 5
Multidrug-Resistant Candida in Bloodstream Infections: A Growing Concern in Indian Healthcare
Yadav, S. K., Himanshu, D., Gupta, P., Nischal, A., Atam, V., Ali, W., Yadav, A., Sonkar, V., & Kumar, V. (2025) · Cureus · doi:10.7759/cureus.85420 · Cited by 5
İşbilir, H., Kaya, H. O., Tekintaş, Y., Kurul, F., Çetin, A. E., & Topkaya, S. N. (2025) · Microchemical Journal · doi:10.1016/j.microc.2025.114513 · Cited by 5
Clinical Manifestations of Candidiasis: Beyond Candida albicans
Hanna, M. C. (2019) · Virology & Immunology Journal · doi:10.23880/vij-16000219 · Cited by 5
“One primary concern with anti- Candida antibody assays is their sensitivity, which may be reduced in immunocompromised patients and a positive result may not differentiate previous infections [136].”
BackgroundChen, L., Feng, J., Hu, X., Bao, H., Luan, F., & Tao, Y. K. (2022) · Retina · doi:10.1097/iae.0000000000003491 · Cited by 5
Point-of-Care Testing for the Diagnosis of Fungal Infections
Luethy, P. M. (2023) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2023.02.005 · Cited by 5
Challenges in management of invasive fungal infections in stem cell transplant
Walker, J. B., Edwards, S., Hall, N. M., & Pappas, P. G. (2023) · Transplant Infectious Disease · doi:10.1111/tid.14175 · Cited by 5
“However, blood cultures are only positive in 50%–80% of primary candidemia episodes 14 ; thus, there remains a need to consider non-culture-based testing (1,3 B-D glucan or T2Candida ® ) and empiric treatment when suspicion is high (hepatosplenic involvement, persisting fever despite broad…”
BackgroundUpdate on Non-Culture-Based Diagnostics for Invasive Fungal Disease
Yan, G. Z., Chew, K. L., & Chai, L. Y. A. (2021) · Mycopathologia · doi:10.1007/s11046-021-00549-x · Cited by 5
Tertiary Care - Medical, Psychosocial, and Environmental Aspects
Önal, A. E. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.110957 · Cited by 5
Update on the Diagnosis of Candidemia and Invasive Candidiasis
González-Lara, M. F., & Ostrosky-Zeichner, L. L. (2019) · Current Fungal Infection Reports · doi:10.1007/s12281-019-00367-1 · Cited by 5
Bouza, E., Vena, A., Muñóz, P., T2MadRid study group, Bouza, E., Machado, M., Martínez-Jiménez, C., Muñóz, P., Navarro, R., Pérez-Granda, M. J., et al. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky460 · Cited by 5
Rivas-Pinedo, P., & Oñate, J. (2026) · Journal of Fungi · doi:10.3390/jof12070498 · Cited by 4
Luo, T., Li, X., Yan, H., Gong, L., Xie, L., Wang, X., Huang, J., Yang, Y., Li, X., Zhang, Y., et al. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.03245-24 · Cited by 4
“Negatives in reference method i “/” means there is no result. j NA, Not applicable. infections, lacking specificity (3, 17–22).”
Update on the diagnosis of parasitic and fungal infections
Fréalle, É., Valot, S., Piarroux, R., Ménotti, J., Lachaud, L., Persat, F., Izri, A., Villard, O., Yera, H., Dannaoui, É., et al. (2020) · Annales de biologie clinique · doi:10.1684/abc.2020.1554 · Cited by 4
Diagnosis and Management of Invasive Candida Infections in Critically Ill Patients
Zakhem, A. E., Istambouli, R., Jabbour, J.-F., Hindy, J.-R., Gharamti, A. A., & Kanj, S. S. (2022) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0041-1741009 · Cited by 4
Stewart, A. G., Heney, C., Paterson, D. L., Harris, P. N. A., Edwards, F., & Laupland, K. B. (2023) · Internal Medicine Journal · doi:10.1111/imj.16198 · Cited by 4
Diagnostic Value of Serum Biomarkers for Invasive Aspergillosis in Haematologic Patients
Montesinos, I., Albichr, I. S., Collinge, E., Delaere, B., Huang, T., Bogaerts, P., Deckers, C., Hamouda, M., Honoré, P. M., Bulpa, P. A., et al. (2024) · Journal of Fungi · doi:10.3390/jof10090661 · Cited by 4
“This makes it a valuable tool for ruling out fungal infections in patients with suspected invasive fungal infections (IFIs) [14,17–19].”
MethodDiagnostic Algorithm for Invasive Fungal Infections
Khan, Z., & Ahmad, S. (2019) · Springer eBooks · doi:10.1007/978-981-13-9459-1_12 · Cited by 4
Diagnostics: The Role of the Laboratory
Afzal, A., Kaplan, H. M., Motazedi, T., Qureshi, T. M., & Woc-Colburn, L. E. (2020) · Springer eBooks · doi:10.1007/978-3-030-33803-9_4 · Cited by 4
Updated estimated incidence and prevalence of serious fungal infections in Trinidad and Tobago
Edwards, R. J., Boyce, G., Alastruey‐Izquierdo, A., & Denning, D. W. (2021) · IJID Regions · doi:10.1016/j.ijregi.2021.09.007 · Cited by 4
Fungal Infections in Cancer Patients
Granwehr, B. P., & Kontoyiannis, D. P. (2021) · Springer eBooks · doi:10.1007/978-3-319-74698-2_121-2 · Cited by 4
EFFECT OF HEMEROCALLIS FULVA L. EXTRACTS ON SOME STRAINS OF MICROORGANISMS
Vorobets, N. M., Yavorska, H. V., Kuzelyak, H. V., & Voroniuk, O. M. (2023) · Ukrainian Journal of Laboratory Medicine · doi:10.62151/2786-9288.1.2.2023.01 · Cited by 4
Management of invasive candidiasis in French ICUs: insights from a 2024 nationwide survey
Esposito, M., Lemery, F., Agrinier, N., Soudant, M., Charmillon, A., Degand, N., Dorin, J., Dellamonica, J., Morand, L., Roger, C., et al. (2025) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-025-05169-7 · Cited by 3
“Therefore, the diagnosis of IC also relies on clinical score and biomarkers [10].”
Kılıç, Ö., & Demircan, E. (2025) · The Journal of Critical Care Medicine · doi:10.2478/jccm-2025-0034 · Cited by 3
“Early recognition and timely antifungal therapy are essential, especially given the diagnostic delays and poor outcomes often seen in this population [31, 32].”
Omics and Multiomics-Based Diagnostics for Invasive Candidiasis: Toward Precision Medicine
Pitarch, A., Arribas, V., & Gil, C. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.101463 · Cited by 3
“Histopathological examination of normally sterile sites (the other reference standard of IC) has reduced diagnostic sensitivity, and may be very risky in critically ill or unstable patients and contraindicated in patients with severe thrombocytopenia or coagulopathies (14, 18).”
Diagnosis and Management of Candidemia and Invasive Candidiasis in Neonates and Children
Warris, A., & Ferreras-Antolin, L. (2025) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000005082 · Cited by 3
Progress on nonculture based diagnostic tests for invasive mould infection
White, P. L. (2024) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000001060 · Cited by 3
Antifungal Resistance in Candida albicans
Seyedjavadi, S. S., Hatami, F., & Jahanshiri, Z. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1004578 · Cited by 3
Current nonculture-based diagnosis of candidemia
Won, E. J. (2024) · Annals of Clinical Microbiology · doi:10.5145/acm.2024.27.4.4 · Cited by 3
Review on the management of intra-abdominal candidiasis
Puerta‐Alcalde, P., Guinea, J., Maseda, E., & Zaragoza, R. (2025) · Revista Española de Quimioterapia · doi:10.37201/req/095.2025 · Cited by 3
“IAC is commonly a consequence of Candida access into the abdominal cavity following gastrointestinal tract disruption; of note, only 5 to 20% of cases will develop secondary candidemia [12 ].”
Черновецкий, М. А., Кондаурова, С. Л., Кульбицкая, Т. Т., Литуновская, Л. Г., Райко, Т. В., & Skopovets, E. (2021) · Лабораторная диагностика Восточная Европа · doi:10.34883/pi.2021.10.2.006 · Cited by 3
Kotgire, S., & Hatkar, S. S. (2024) · IP International Journal of Medical Microbiology and Tropical Diseases · doi:10.18231/j.ijmmtd.2024.027 · Cited by 3
García-Lechuz, J. M., & Arias, A. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.02.027 · Cited by 3
Candidemia por Candida glabrata : revisão de literatura
Cardoso, C. M. (2020) · Lume (Universidade Federal do Rio Grande do Sul) · Cited by 3
Diagnostics of Candida and Candidiasis: Current Methods and Future Perspectives
Banik, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-4909-6_1 · Cited by 2
Akazawa, H., Fukushima, S., Higuchi, T., Miyoshi, T., Nakano, Y., Iio, K., Akamatsu, Y., Haruki, Y., Iwamoto, Y., Tanaka, S., et al. (2025) · Mycopathologia · doi:10.1007/s11046-025-00999-7 · Cited by 2
“The diagnostic performance of BDG for candidemia demonstrates a sensitivity ranging 55–92%, specificity ranging 60–80%, and a notably high negative predictive value of 97% or higher [4, 23].”
Fungal Infections Associated with Primary and Secondary Immunodeficiencies
Galván-Hernández, A. K., Gómez-Gaviria, M., & Mora-Montes, H. M. (2025) · Fungal biology · doi:10.1007/978-3-032-06014-3_2 · Cited by 2
An update on antimicrobial selection and duration for intra-abdominal infections
Lee, Y.-L., & Hsueh, P. (2025) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2025.2580451 · Cited by 2
Metadata
- Authors
- Clancy, C. J., & Nguyen, M. H.
- Affiliations
- University of Pittsburgh (US)
- VA Pittsburgh Healthcare System (US)
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2018-05
- Volume
- 56
- Issue
- 5
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC5925725
- OpenAlex
- W2790020787
- Cited by
- 293
- References
- 30
- Citations by year
- 2026: 30 · 2025: 38 · 2024: 34 · 2023: 46 · 2022: 38 · 2021: 45 · 2020: 33 · 2019: 21 · 2018: 8
- FWCI
- 3.92
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Keywords
- invasive candidiasis, candidemia, germ tube test, β-1,3-glucan, PCR, diagnostic performance, positive predictive value, negative predictive value, pretest probability
- MeSH terms
- Clinical Decision-Making, Antibodies, Fungal, Antigens, Fungal, Candida, DNA, Fungal, Sensitivity and Specificity, Clinical Laboratory Techniques, Candidiasis, Invasive, Intraabdominal Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.